Selected research
Market Structure
Global Shield Minimally Invasive Fascial Closure Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Shield Minimally Invasive Fascial Closure Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Shield Minimally Invasive Fascial Closure Device include EndoSystem, Dongfeng Yihe, WODELIPAI, Weipu Medical, Teleflex, Shandong Bainus Medical Instrumen, Medtronic, Longmed and Golden Stapler Surgical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Shield Minimally Invasive Fascial Closure Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Shield Minimally Invasive Fascial Closure Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Shield Minimally Invasive Fascial Closure Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Shield Minimally Invasive Fascial Closure Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Shield Minimally Invasive Fascial Closure Device Segment by Company
EndoSystem
Dongfeng Yihe
WODELIPAI
Weipu Medical
Teleflex
Shandong Bainus Medical Instrumen
Medtronic
Longmed
Golden Stapler Surgical
Double Medical Technology
Portoria Medical
Aofo
Suture Ease
CooperSurgical
Anrei Sinolinrs
Shield Minimally Invasive Fascial Closure Device Segment by Type
Shell Diameter 16mm or More
Shell Diameter 13mm-16mm
Shell Diameter 10mm-13mm
Shield Minimally Invasive Fascial Closure Device Segment by Application
Hospital
Clinic
Shield Minimally Invasive Fascial Closure Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Shield Minimally Invasive Fascial Closure Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Shield Minimally Invasive Fascial Closure Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Shield Minimally Invasive Fascial Closure Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Shield Minimally Invasive Fascial Closure Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shield Minimally Invasive Fascial Closure Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Shield Minimally Invasive Fascial Closure Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Shield Minimally Invasive Fascial Closure Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Shell Diameter 16mm or More
- Shell Diameter 13mm-16mm
- Shell Diameter 10mm-13mm
Applications
- Hospital
- Clinic
Companies covered
- EndoSystem
- Dongfeng Yihe
- WODELIPAI
- Weipu Medical
- Teleflex
- Shandong Bainus Medical Instrumen
- Medtronic
- Longmed
- Golden Stapler Surgical
- Double Medical Technology
- Portoria Medical
- Aofo
- Suture Ease
- CooperSurgical
- Anrei Sinolinrs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Shield Minimally Invasive Fascial Closure Device Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Shield Minimally Invasive Fascial Closure Device Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Shield Minimally Invasive Fascial Closure Device Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Shield Minimally Invasive Fascial Closure Device Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Shield Minimally Invasive Fascial Closure Device Market Dynamics
- 2.1 Shield Minimally Invasive Fascial Closure Device Industry Trends
- 2.2 Shield Minimally Invasive Fascial Closure Device Industry Drivers
- 2.3 Shield Minimally Invasive Fascial Closure Device Industry Opportunities and Challenges
- 2.4 Shield Minimally Invasive Fascial Closure Device Industry Restraints
3 Shield Minimally Invasive Fascial Closure Device Market by Manufacturers
- 3.1 Global Shield Minimally Invasive Fascial Closure Device Revenue by Manufacturers (2021-2026)
- 3.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Manufacturers (2021-2026)
- 3.3 Global Shield Minimally Invasive Fascial Closure Device Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Shield Minimally Invasive Fascial Closure Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Shield Minimally Invasive Fascial Closure Device Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Shield Minimally Invasive Fascial Closure Device Manufacturers, Product Type & Application
- 3.7 Global Shield Minimally Invasive Fascial Closure Device Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Shield Minimally Invasive Fascial Closure Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Shield Minimally Invasive Fascial Closure Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Shield Minimally Invasive Fascial Closure Device Tier 1, Tier 2, and Tier 3
4 Shield Minimally Invasive Fascial Closure Device Market by Type
- 4.1 Shield Minimally Invasive Fascial Closure Device Type Introduction
- 4.1.1 Shell Diameter 16mm or More
- 4.1.2 Shell Diameter 13mm-16mm
- 4.1.3 Shell Diameter 10mm-13mm
- 4.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Type
- 4.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Type (2021-2032)
- 4.2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Type (2021-2032)
- 4.3 Global Shield Minimally Invasive Fascial Closure Device Revenue by Type
- 4.3.1 Global Shield Minimally Invasive Fascial Closure Device Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Type (2021-2032)
- 4.3.3 Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Type (2021-2032)
5 Shield Minimally Invasive Fascial Closure Device Market by Application
- 5.1 Shield Minimally Invasive Fascial Closure Device Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Application
- 5.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Application (2021-2032)
- 5.2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Application (2021-2032)
- 5.3 Global Shield Minimally Invasive Fascial Closure Device Revenue by Application
- 5.3.1 Global Shield Minimally Invasive Fascial Closure Device Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Application (2021-2032)
- 5.3.3 Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Application (2021-2032)
6 Global Shield Minimally Invasive Fascial Closure Device Sales by Region
- 6.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2021-2032)
- 6.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2021-2026)
- 6.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Shield Minimally Invasive Fascial Closure Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Shield Minimally Invasive Fascial Closure Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Shield Minimally Invasive Fascial Closure Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region
- 7.1 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region
- 7.1.1 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region (2021-2026)
- 7.1.3 Global Shield Minimally Invasive Fascial Closure Device Revenue by Region (2027-2032)
- 7.1.4 Global Shield Minimally Invasive Fascial Closure Device Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Shield Minimally Invasive Fascial Closure Device Revenue (2021-2032)
- 7.2.2 North America Shield Minimally Invasive Fascial Closure Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Shield Minimally Invasive Fascial Closure Device Revenue (2021-2032)
- 7.3.2 Europe Shield Minimally Invasive Fascial Closure Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Revenue (2021-2032)
- 7.4.2 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Shield Minimally Invasive Fascial Closure Device Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Shield Minimally Invasive Fascial Closure Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 EndoSystem
- 8.1.1 EndoSystem Company Information
- 8.1.2 EndoSystem Business Overview
- 8.1.3 EndoSystem Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 EndoSystem Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.1.5 EndoSystem Recent Developments
- 8.2 Dongfeng Yihe
- 8.2.1 Dongfeng Yihe Company Information
- 8.2.2 Dongfeng Yihe Business Overview
- 8.2.3 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.2.5 Dongfeng Yihe Recent Developments
- 8.3 WODELIPAI
- 8.3.1 WODELIPAI Company Information
- 8.3.2 WODELIPAI Business Overview
- 8.3.3 WODELIPAI Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 WODELIPAI Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.3.5 WODELIPAI Recent Developments
- 8.4 Weipu Medical
- 8.4.1 Weipu Medical Company Information
- 8.4.2 Weipu Medical Business Overview
- 8.4.3 Weipu Medical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Weipu Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.4.5 Weipu Medical Recent Developments
- 8.5 Teleflex
- 8.5.1 Teleflex Company Information
- 8.5.2 Teleflex Business Overview
- 8.5.3 Teleflex Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teleflex Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.5.5 Teleflex Recent Developments
- 8.6 Shandong Bainus Medical Instrumen
- 8.6.1 Shandong Bainus Medical Instrumen Company Information
- 8.6.2 Shandong Bainus Medical Instrumen Business Overview
- 8.6.3 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.6.5 Shandong Bainus Medical Instrumen Recent Developments
- 8.7 Medtronic
- 8.7.1 Medtronic Company Information
- 8.7.2 Medtronic Business Overview
- 8.7.3 Medtronic Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Medtronic Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.7.5 Medtronic Recent Developments
- 8.8 Longmed
- 8.8.1 Longmed Company Information
- 8.8.2 Longmed Business Overview
- 8.8.3 Longmed Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Longmed Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.8.5 Longmed Recent Developments
- 8.9 Golden Stapler Surgical
- 8.9.1 Golden Stapler Surgical Company Information
- 8.9.2 Golden Stapler Surgical Business Overview
- 8.9.3 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.9.5 Golden Stapler Surgical Recent Developments
- 8.10 Double Medical Technology
- 8.10.1 Double Medical Technology Company Information
- 8.10.2 Double Medical Technology Business Overview
- 8.10.3 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.10.5 Double Medical Technology Recent Developments
- 8.11 Portoria Medical
- 8.11.1 Portoria Medical Company Information
- 8.11.2 Portoria Medical Business Overview
- 8.11.3 Portoria Medical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Portoria Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.11.5 Portoria Medical Recent Developments
- 8.12 Aofo
- 8.12.1 Aofo Company Information
- 8.12.2 Aofo Business Overview
- 8.12.3 Aofo Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Aofo Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.12.5 Aofo Recent Developments
- 8.13 Suture Ease
- 8.13.1 Suture Ease Company Information
- 8.13.2 Suture Ease Business Overview
- 8.13.3 Suture Ease Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Suture Ease Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.13.5 Suture Ease Recent Developments
- 8.14 CooperSurgical
- 8.14.1 CooperSurgical Company Information
- 8.14.2 CooperSurgical Business Overview
- 8.14.3 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 CooperSurgical Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.14.5 CooperSurgical Recent Developments
- 8.15 Anrei Sinolinrs
- 8.15.1 Anrei Sinolinrs Company Information
- 8.15.2 Anrei Sinolinrs Business Overview
- 8.15.3 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Product Portfolio
- 8.15.5 Anrei Sinolinrs Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Shield Minimally Invasive Fascial Closure Device Value Chain Analysis
- 9.1.1 Shield Minimally Invasive Fascial Closure Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Shield Minimally Invasive Fascial Closure Device Production Mode & Process
- 9.2 Shield Minimally Invasive Fascial Closure Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Shield Minimally Invasive Fascial Closure Device Distributors
- 9.2.3 Shield Minimally Invasive Fascial Closure Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst